Standout Papers

Adalimumab for induction of clinical remission in moderately to severel... 2006 2026 2012 2019 662
  1. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial (2011)
    Walter Reinisch, William J. Sandborn et al. Gut
  2. Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease (2009)
    Filip Baert, Liesbeth Moortgat et al. Gastroenterology
  3. A Phase I Trial With Transgenic Bacteria Expressing Interleukin-10 in Crohn’s Disease (2006)
    Henri Braat, Pieter Rottiers et al. Clinical Gastroenterology and Hepatology

Immediate Impact

3 by Nobel laureates 5 from Science/Nature 93 standout
Sub-graph 1 of 16

Citing Papers

Crohn's disease
2024 Standout
Ulcerative colitis
2023 Standout
137 intermediate papers

Works of Daniël W. Hommes being referenced

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
2011 Standout
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
and 44 more

Author Peers

Author Last Decade Papers Cites
Daniël W. Hommes 5411 3654 2849 216 12.3k
Ole Haagen Nielsen 5753 3663 3388 340 14.1k
Hans Herfarth 4615 4079 2956 261 11.8k
Axel Dignaß 9666 6862 4949 272 16.7k
Arthur Kaser 3135 4149 2365 153 13.8k
Claudio Fiocchi 6885 3771 3693 243 15.2k
Sander J. H. van Deventer 7589 7651 4858 267 21.8k
Judy H. Cho 6012 3040 2577 167 11.9k
Stephan R. Vavricka 5204 4162 2889 237 10.6k
Lloyd Mayer 9267 6730 3929 183 18.8k
Édouard Louis 8614 6324 3811 372 13.1k

All Works

Loading papers...

Rankless by CCL
2026